Our proteomic analysis identified Del-1 protein and confirmed its increased presence in MVs isolated from plasma tumor patients, compared to controls from healthy subjects, as well as in many tumor biopsies of GCTB patients. This evidence concerns the gene EDIL3 and neoplasm.